Pan-cancer (>15 solid tumors including CRC, GC) with MSI-H/dMMR, mono, single-arm, ORR, 2L/3L

BTC, combo with chemo vs. chemo, randomized, OS, 1L

SC, mono, single-arm, ORR, 2L

NSCLC, combo, 1L

NSCLC, combo, 2L

GC, combo, 1L/2L

TMB-H, mono, single-arm, 2L/3L

EC, single-arm, combo with lenvatinib, 2L

HCC, combo with VEGF inhibitor, 1L/2L

RCC, combo with VEGF inhibitor, 1L/2L

NSCLC/OC/Kidney cancer/Pancreatic cancer

OC/Kidney cancer/Bladder cancer

BTC/mUC

Multiple indications

Multiple indications

Multiple indications